The AAHP Summit: Implementing HPUS Guidelines for FDA Compliance
AAHP is committed to advancing quality and safety throughout the homeopathic industry. That’s why we’re pleased to offer a free summary slide deck of this year’s Summit presentations. The Sept. 23, 2020 virtual event was packed with must-know insights and resources to help you keep compliant with FDA guidelines. Explore the Summit content, including:
- Keynote speaker Francis Godwin, MBA, director, FDA Office of Manufacturing Quality, Office of Compliance, reviews trends in FDA inspections of homeopathic drug manufacturers.
- Emily N. Babik, Ph.D., vice president, Research & Development, Hyland’s Inc., a division of Standard Homeopathic Co., offers an overview of the five technical gaps that challenge both industry and FDA investigators during inspections.
- Adam W. Grobin, Ph.D., independent consultant, has tackled the first of the gaps — and presents a guideline for validating dilution processes when manufacturers prepare Hahnemannian liquids.
A complete recording of the AAHP Summit: Implementing HPUS Guidelines for FDA Compliance, as well as four full PowerPoint slide decks from presenters, are available for purchase below.
AAHP Non Member Price: $99.00
Name: 2020 Summit Presentation Deck
Product Description: AAHP Summit September 2020: Implementing HPUS Guidelines for FDA Compliance | Presentation Deck
AAHP Non Member Price: $249.00
Name: 2020 Summit Presentation Deck and Videos
Product Description: AAHP Summit September 2020: Implementing HPUS Guidelines for FDA Compliance | Presentation Deck and Videos
2020 Summit Presentation Deck
2020 Summit Presentation Deck and Video Archives